Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melania Scarpa

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Surgery|November 21, 2024
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Cesare Ruffolo, Melania Scarpa, et al.
Scientific Reports|November 30, 2024
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Melania Scarpa, Valerio Pellegrini, et al.
Cancer|April 22, 2024
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Melania Scarpa, Ignazio Castagliuolo, et al.
Cancers|February 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerOttavia De Simoni, Melania Scarpa, Francesco Cavallin, et al.
Cancers|June 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 StudyLorenzo Dell'Atti, Andromachi Kotsafti, Francesca Galuppini, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Surgery|November 21, 2024
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Cesare Ruffolo, Melania Scarpa, et al.
Scientific Reports|November 30, 2024
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Melania Scarpa, Valerio Pellegrini, et al.
Cancer|April 22, 2024
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Melania Scarpa, Ignazio Castagliuolo, et al.
Cancers|February 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerOttavia De Simoni, Melania Scarpa, Francesco Cavallin, et al.
Cancers|June 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 StudyLorenzo Dell'Atti, Andromachi Kotsafti, Francesca Galuppini, et al.
Pageof 7